Procept BioRobotics Eyes 2025 Growth Amid Challenges Procept BioRobotics has outlined an ambitious plan for 2025, targeting 40% revenue growth and aiming to place 210 systems in the U.S. Despite facing setbacks, such as saline shortages impacting Q4 2024 procedures, the company remains optimistic, bolstered by international expansion and prostate cancer trials.12